Home Top News and Stories Business News Headlines Theratechnologies to Host Key Opinion Leader Event to Discuss its SORT1+ Technology™ for the Treatment of All Sortilin-Expressing Cancers

Theratechnologies to Host Key Opinion Leader Event to Discuss its SORT1+ Technology™ for the Treatment of All Sortilin-Expressing Cancers

0
   

Theratechnologies to Host Key Opinion Leader Event to Discuss its SORT1+ Technology™ for the Treatment of All Sortilin-Expressing Cancers

MONTREAL, June 10, 2021 (GLOBE NEWSWIRE) — Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that it will host a key opinion leader (KOL) webinar on the Company’s SORT1+ Technology™ and TH1902, its lead investigational peptide-drug conjugate (PDC) for treating sortilin-expressing advanced solid tumors, on Monday, June 21, 2021 at 11:00 a.m. Eastern Time. Read More